Development of a health communication campaign to promote the Texas prescription monitoring program
Given the role opioid overprescribing has played in the current overdose crisis, reducing the supply of prescription opioids available for misuse has gained widespread support. Prescription monitoring programs (PMPs) have been identified as a tool for achieving this goal, but little is known about how to promote PMP use to prescribers. This paper describes the process of developing a health communication campaign to support the adoption of the Texas PMP. After formative research, message development and concept testing, a range of campaign concepts and messages were tested and final recommendations determined. The messages and lessons learned have utility beyond Texas.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Health marketing quarterly - 37(2020), 3 vom: 23. Juli, Seite 222-231 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mackert, Michael [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Analgesics, Opioid |
|---|
| Anmerkungen: |
Date Completed 12.07.2021 Date Revised 12.07.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/07359683.2020.1802967 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313652112 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313652112 | ||
| 003 | DE-627 | ||
| 005 | 20231225151031.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/07359683.2020.1802967 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1045.xml |
| 035 | |a (DE-627)NLM313652112 | ||
| 035 | |a (NLM)32790502 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mackert, Michael |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development of a health communication campaign to promote the Texas prescription monitoring program |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.07.2021 | ||
| 500 | |a Date Revised 12.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Given the role opioid overprescribing has played in the current overdose crisis, reducing the supply of prescription opioids available for misuse has gained widespread support. Prescription monitoring programs (PMPs) have been identified as a tool for achieving this goal, but little is known about how to promote PMP use to prescribers. This paper describes the process of developing a health communication campaign to support the adoption of the Texas PMP. After formative research, message development and concept testing, a range of campaign concepts and messages were tested and final recommendations determined. The messages and lessons learned have utility beyond Texas | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Health communication | |
| 650 | 4 | |a opioid | |
| 650 | 4 | |a prescription monitoring program | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 700 | 1 | |a Pounders, Kathrynn |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Laura E |e verfasserin |4 aut | |
| 700 | 1 | |a Kirtz, Susan |e verfasserin |4 aut | |
| 700 | 1 | |a Wagner, Jessica Hughes |e verfasserin |4 aut | |
| 700 | 1 | |a Ring, David |e verfasserin |4 aut | |
| 700 | 1 | |a Hill, Lucas |e verfasserin |4 aut | |
| 700 | 1 | |a Wilcox, Gary |e verfasserin |4 aut | |
| 700 | 1 | |a Murthy, Dhiraj |e verfasserin |4 aut | |
| 700 | 1 | |a Tierney, William |e verfasserin |4 aut | |
| 700 | 1 | |a Innerarity, Sheri |e verfasserin |4 aut | |
| 700 | 1 | |a McGlone, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Holleran Steiker, Lori K |e verfasserin |4 aut | |
| 700 | 1 | |a DeSalvo, Karen |e verfasserin |4 aut | |
| 700 | 1 | |a Bernhardt, Jay M |e verfasserin |4 aut | |
| 700 | 1 | |a Pretorius, Kelly |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Health marketing quarterly |d 1983 |g 37(2020), 3 vom: 23. Juli, Seite 222-231 |w (DE-627)NLM082812837 |x 1545-0864 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2020 |g number:3 |g day:23 |g month:07 |g pages:222-231 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/07359683.2020.1802967 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2020 |e 3 |b 23 |c 07 |h 222-231 | ||